Paul W Jones Selected Research

Paul W Jones Research Topics

Disease

86	Chronic Obstructive Pulmonary Disease (COPD) 08/2022 - 10/2003
7	Dyspnea (Shortness of Breath) 01/2021 - 04/2006
6	Shock 05/2014 - 08/2011
5	Heart Failure 01/2022 - 01/2009
4	Cardiac Arrhythmias (Arrythmia) 03/2021 - 10/2013
4	Pneumonia (Pneumonitis) 01/2015 - 02/2007
3	Inflammation (Inflammations) 01/2022 - 01/2016
3	Asthma (Bronchial Asthma) 01/2022 - 08/2010
3	Emphysema 11/2019 - 10/2014
3	Disease Progression 09/2010 - 03/2002
2	COVID-19 01/2022 - 03/2021
2	Atrial Fibrillation 01/2022 - 09/2011
2	Stroke (Strokes) 01/2016 - 01/2013
2	Respiratory Insufficiency (Respiratory Failure) 01/2016 - 03/2006
2	Eosinophilia 01/2016 - 08/2010
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022
1	Cognitive Dysfunction 01/2019
1	Airway Remodeling 02/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 02/2018
1	Atrophy 06/2017
1	Diabetes Mellitus 01/2016
1	Lung Diseases (Lung Disease) 01/2016
1	Ventricular Tachycardia 05/2014
1	Hypertension (High Blood Pressure) 01/2014
1	Metabolic Diseases (Metabolic Disease) 01/2014
1	Chronic Disease (Chronic Diseases) 09/2013
1	Fatigue 09/2013
1	Pulmonary Atelectasis 06/2012
1	Disease Attributes 09/2010
1	Bone Fractures (Bone Fracture) 12/2009
1	Muscle Weakness 06/2008
1	Neuromuscular Diseases (Neuromuscular Disease) 03/2006
1	Premenstrual Syndrome (Premenstrual Tension) 06/2002
1	Pulmonary Sarcoidosis 03/2002

Drug/Important Bio-Agent (IBA)

23	Bronchodilator Agents (Bronchodilators)IBA 08/2022 - 08/2008
22	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2022 - 03/2002
15	GoldIBA 11/2019 - 06/2009
14	Salmeterol Xinafoate (Serevent)FDA Link 08/2022 - 02/2007
13	Biomarkers (Surrogate Marker)IBA 01/2019 - 09/2007
10	vilanterolIBA 08/2022 - 05/2013
8	GSK573719IBA 08/2022 - 10/2019
7	Fluticasone (Cutivate)FDA LinkGeneric 02/2016 - 02/2007
6	Formoterol Fumarate (Oxis)FDA Link 01/2022 - 08/2010
6	aclidinium bromideIBA 01/2016 - 04/2011
4	Muscarinic AntagonistsIBA 01/2021 - 04/2011
4	Tiotropium Bromide (Spiriva)FDA Link 01/2018 - 12/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 06/2015
3	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2019 - 01/2011
3	prednylidene (Pred)IBA 01/2019 - 06/2017
2	Albuterol (Salbutamol)FDA LinkGeneric 01/2020 - 10/2003
2	Blood Glucose (Blood Sugar)IBA 01/2019 - 01/2016
2	Pharmaceutical PreparationsIBA 03/2017 - 02/2017
2	SmokeIBA 12/2016 - 06/2014
2	Oxygen (Dioxygen)IBA 01/2016 - 04/2006
2	fluticasone furoate FDA Link 01/2015 - 05/2013
2	indacaterolIBA 12/2011 - 06/2011
1	BromidesIBA 08/2022
1	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2022
1	MacrolidesIBA 01/2022
1	CytokinesIBA 02/2018
1	Antimicrobial PeptidesIBA 02/2018
1	Vitamin D FDA LinkGeneric 02/2018
1	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 01/2018
1	Indicators and Reagents (Reagents)IBA 06/2017
1	mepolizumabIBA 01/2017
1	Biological ProductsIBA 01/2016
1	FructosamineIBA 01/2016
1	Metformin (Glucophage)FDA LinkGeneric 01/2016
1	Transfer Factor (Factor, Transfer)IBA 01/2016
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2016
1	C-Reactive ProteinIBA 01/2016
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 06/2015
1	CC ChemokinesIBA 01/2015
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2015
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2015
1	LigandsIBA 01/2015
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2014
1	dimemorfan (AT 17)IBA 01/2014
1	Adenosine Triphosphate (ATP)IBA 05/2013
1	Beclomethasone (Beclometasone)FDA Link 01/2013
1	10-N-nonylacridinium orange (NAO)IBA 07/2012
1	salicylhydroxamic acid (SHAM)IBA 06/2012
1	Budesonide (Pulmicort)FDA LinkGeneric 08/2010
1	Moxifloxacin (Avelox)FDA Link 01/2010
1	HeliumIBA 04/2006
1	Progestins (Progestagens)IBA 06/2002
1	Progesterone FDA LinkGeneric 06/2002

Therapy/Procedure

35	Therapeutics 08/2022 - 03/2002
6	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 05/2013
4	Cardiac Resynchronization Therapy 01/2022 - 01/2009
4	Nebulizers and Vaporizers (Inhaler) 01/2021 - 01/2013
3	Drug Therapy (Chemotherapy) 01/2016 - 06/2008
2	Activities of Daily Living (ADL) 08/2012 - 06/2008
2	Critical Care (Surgical Intensive Care) 07/2011 - 03/2006
1	Defibrillators (Defibrillator) 03/2021
1	Length of Stay 07/2013
1	Transcranial Magnetic Stimulation 01/2013
1	Glycemic Control 07/2011
1	Noninvasive Ventilation 03/2006
1	Artificial Respiration (Mechanical Ventilation) 03/2006